Skip to main content
. 2017 May 19;3(5):e00305. doi: 10.1016/j.heliyon.2017.e00305

Fig. 5.

Fig. 5

Immunohistochemistry for macrophages: F4/80 (A and B), for neutrophils: myeoperoxidase (D and E) and for T lymphocytes: CD3 (G and H) in livers of control (A, D, G) and caAlk5/Alb-Cre mice (B, E, H) treated with TAA for 12 weeks. Quantification of F4/80-(C), myeloperoxidase-(F), and CD3-(I) positive cells in livers from saline-treated and TAA-treated mice. Data represent means ± SD, n = 5 mice per experimental group, ten 20x fields per mouse. There is a significant difference after TAA treatment when compared with genotype-specific saline control (*P < 0.05). There is a significant difference when compared with genotype-specific saline control and between genotypes after TAA treatment (**P < 0.05). Immunochemistry with NovaRed substrate, counterstained with hematoxylin. CV denotes the central vein. PT denotes the portal tract.